ANI Pharmaceuticals Inc (ANIP)

Receivables turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Revenue (ttm) US$ in thousands 614,376 555,456 538,953 517,460 486,816 449,394 401,386 358,694 316,385 283,082 251,322 226,092 216,136 212,459 213,377 213,222 208,475 199,189 197,547 203,434
Receivables US$ in thousands
Receivables turnover

December 31, 2024 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $614,376K ÷ $—K
= —

The receivables turnover ratio for ANI Pharmaceuticals Inc is not available for the period from March 31, 2020, to December 31, 2024, based on the provided data. Receivables turnover is a financial metric that measures how efficiently a company is able to collect payments from its customers on credit sales. A higher receivables turnover ratio indicates that the company is collecting its accounts receivable more quickly, which is generally considered positive as it reflects effective management of credit and collections. On the other hand, a low receivables turnover ratio may suggest that the company is extending credit to customers who are slow to pay, potentially leading to cash flow issues.

Without the receivables turnover data for ANI Pharmaceuticals Inc, it is challenging to assess the effectiveness of the company's credit management and collection practices. This ratio is essential for evaluating the company's liquidity, operational efficiency, and overall financial health. Monitoring changes in the receivables turnover ratio over time can provide valuable insights into the company's performance and help investors and analysts make informed decisions.